+ 86 (1812) 4514114 info@phcoker.com

Paheʻe Phenylpiracetam kaola (77472-70-9)

ʻO Phenylpiracetam (4 fenilpiratsetam "Phenotropil") he nootropic stimulant synthetic kaha. ʻO ka Phenylpiracetam ka pauka .. ......


Kūlana: I ka Production Production
Mokuna: 25kg / Drum
nona iho: 1350kg / ka mahina

Description

ʻO ka wikiwikiʻo Rahen Phenylpiracetam (77472-70-9) wikiō

Paheʻe Phenylpiracetam ka paukū (77472-70-9) Hōʻike

ʻO ka Pōkakela Phenylpiracetam ka lāʻau nootropic kaha, He mea hoʻouluulu nui ia e hiki ai ke hoʻonui i keʻano, ka hoʻomanaʻo, kaʻikeʻike, a me ka hanaʻaina.

ʻO ka hanana likeʻole o ka Phenylpiracetam ka lāʻauʻeleʻele like me ka piracetam, me kahi hui pūpili hou. Hāpai ka phenyl i ka māmā o Raw Phenylpiracetam ka pauʻana i ka momona, kaʻaila, a me ka lipids, a laila e hoʻonui i ka laweʻana i loko o ke kino. E wehewehe paha kēia waiwai no ke kumu eʻoi aku ai ka ikaika o ka pahupapamela Raw Phenylpiracetam ma mua o ka piracetam a me keʻano e pakele ai ke koko ʻO ka pale me ka wikiwiki.

ʻO ka lālā Phenylpiracetam ka hana e like me ka ampakine, nā piʻi mau o ka neurotransmitter glutamate e hoʻonāukiukiʻia e ka hoʻouluʻana i nā mea hōʻailona AMPA. Hanaʻia kēia hana me kaʻoihana palekana maikaʻi a hiki ke hana nui i ka mana o Raw Phenylpiracetam ka mea e hiki ai ke hoʻonui i ka hoʻomanaʻo, ka hilinaʻi, a me kaʻike loiloi.

Paheʻe Phenylpiracetam kaheʻe (77472-70-9) Snāʻike

Product Name Paheʻe Phenylpiracetam
Hawaiian Name 4-Phenyl-2-pyrrolidone-1-acetamide; 2- (2-oxo-4-phenylpyrrolidin-1-yl) acetamide; 4-Raw Phenylpiracetam ka paukū
Brand Name Phenotropil; ʻO Carphedon
Kōpana Drug Nootropic (ka huahana GABA)
Kāleka CAS 77472-70-9
InChIKey LYONXVJRBWWGQO-UHFFFAOYSA-N
hakakino F'Oula C12H14N2O2
hakakino Wʻewalu 218.25g / mol
Monoisotopic Mass 218.24
Hoʻolaha Pʻo kaʻaila 126-128oC
Fkū hou Pʻo kaʻaila ʻAʻoheʻikepili no ka loaʻa
ʻO ka Halifa-Ola Nā hola 2-3
kala like 'ole ʻO ka pauma
Solakino I ka PBS, pH 7.2, kahi 10 mg / ml wale nō.
Ska hoʻokele Tka mahana E kūʻai i -20 ° C
Apaukū Hoʻonui i ke ola, ka hoʻomanaʻo, kaʻikeʻike, a me ka hana pāʻani.

maka Phenylpiracetam powder (77472-70-9)

ʻO ka Phenylpiracetam ka lāʻau lāʻau o ka hui o nā lāʻau lapaʻau neuro. MaʻAmelika Hui PūʻIa a me nā wahi'ē aʻe o ka honua, ua hoʻohana nuiʻia ka paukū phpyllpiracetam-ka inoaʻoiai he nootropic, i manaʻoʻia e nā mea he nui e hoʻonui i ka hoʻomanaʻo, ka hilinaʻi, ka huahana, a me ka ikaika o ke kino.

ʻO Phenylpiracetam heʻano i hoʻololiʻia o piracetam i hoʻomohalaʻia ma ka Russian Academy of Sciences ma 1983. Ua hanaʻiaʻo ia he lāʻau hoʻomalu no ka pilikia lōʻihi eʻikeʻia e nā cosmonauts ma nā mīkini manawa lōʻihi.

ʻOiai uaʻimiʻia nā noiʻi kanaka e pili ana i ka hanana Lūkini,ʻo ia ka mea e kōkua ai i ka hoʻoponoponoʻana i nā hana neurological a me nā hana ola i nā lā a pau no ka hōʻehaʻana i nā maʻi, a me ka hoʻoikaikaʻana i ke kaumaha, nāiona.

Phenylpiracetam powder (77472-70-9) Mechanism of Action

I loko o ka lolo, he nui nā hana a phenylpiracetam, aʻo ka hapanui o ia mau mea e hoʻokomo i ka hoʻonani i ka hanaʻana o nā neurotransmitters.

Hana ia e like me ka ampakine, me ka piʻiʻana o ka nui o ka neurotransmitter glutamate e hoʻonāukiukiʻia e ka hoʻouluʻana i nā mea hōʻailona AMPA. Hanaʻia kēia hana me kahiʻoihana palekana aʻoi aku paha i keʻano nui i ka mana o phenylpiracetam e hoʻonui i ka hoʻomanaʻo, ka hilinaʻi, a me kaʻike loiloi.

Nānā nā haʻawina e hōʻike ana i nā'āpana dopamine, ma o ka hoʻonāukiʻana i ka pūnaehana dopaminergic a ma ka hanaʻana i ka hoʻopiʻi hoʻopili dopamine. He mea nui ka laulupransmitter e pili ana i ka uku, hoʻoikaika, hoʻomanaʻo, nā hoʻoikaika kino. Hoʻonuiʻia ka nui o nā dopamine i ke kuleana, ma keʻano he hapa, no ka hopena maikaʻi o phenylpiracetam i ka hoʻoulu, keʻano, a me ka nānā.

ʻO ka Dopamine kekahi mea kiko'ī o ka neurotransmitter norepinephrine, kahi e hoʻonui ai i ka naʻau, i ke koko, a me nā kiʻekiʻe o ka momona a me ke kō i loko o ke koko. Hoʻoholoʻia kēia mau hopena e pili ana i ka ikaika o ka ikaika a me ka ikaika o phenylpiracetam.

E like me nāʻano nootropicsʻano'ē aʻe, phenylpiracetam e hoʻonui i ka hana o ka acetylcholine, i kekahi manawa i kapaʻiaʻo "ke neurotransmitter study" no ka mea, pili loa ia me nāʻano a pau o kaʻike. Ke hoʻohana nei ka lolo i ke kohoʻana no ka hanaʻana i ka acetylcholine a hiki ke hoʻopau koke i kāna mau hale kūʻai i ka laweʻana i nā racetams, aʻo ia ke kumu i'ōleloʻia ai keʻano o ka choline hou e laweʻia me ka phenylpiracetam.

maika of Phenylpiracetam powder (77472-70-9)

  • Ka Hoʻoulu Haumāna a me ka Hoʻoulu Hua
  • Lilo Booster
  • Ka Hoʻohaʻahaʻa haʻahaʻa me ka Antidepressant

pono Phenylpiracetam powder (77472-70-9) Hoʻoponopono

ʻO keʻano phenylpiracetam e like me nā mea pono a me nā noiʻana,ʻo ka palapala hua'ōlelo o 200mg -600mg.

  • Nā 200mg Kūlohelohe (100mg iʻelua mau lā) i ka 600mg (200mgʻekolu manawa)
  • Ma kahi o ka 1 mahina.

E kūʻaiʻia ana ma ka papaʻaina a me ka paukū, ma keʻano o 100 mg kēlā me kēia.

Nā hopenaʻaoʻao of Phenylpiracetam powder (77472-70-9)

E like me nāʻano nootropics i loko o ka papa racetam, he mau hopena hopena i hōʻikeʻia mai ka heluʻana i phenylpiracetam ma nā mea i'ōleloʻia.

Hiki i ka Phenylpiracetam ke hoʻonāuki i nā kuʻihewa no ka mea e hoʻonui i ka hoʻohanaʻana o ka acetylcholine i kou lolo. Hiki i ka Choline ke hoʻolālā e like me Alpha GPC a iʻole CDP-Choline e kōkua iāʻoe e hōʻole i kēiaʻaoʻao.

Hōʻike kekahi mau mea hoʻohana i nā hopena maikaʻiʻole i ka lā ma hope o ka laweʻana i ka phenylpiracetam, e like me ka'ākau a me ka lolo.

ʻO kekahi poʻe e'ōlelo ana i ka laweʻana i nā kau nui o phenylpiracetam e mau ana ma kahi lōʻihi e hiki ai ke pilikia i ka hiamoe, i ke kaumaha, a me ka pilikia o ka naʻau.

NA HALO A E HOOLAHA:

E kūʻai ʻia ana kēia ʻano mea no ka noiʻi noiʻi wale nō. Wahi a ke kūʻai aku. ʻAʻole no ka loiloi kanaka, ʻaʻole lāʻau lapaʻau, manu hoʻāno, a i ʻole e kōkua ʻia nā mea hale.


=

Nāʻike & nā hua'ōlelo huahana

Nootropics Phenylpiracetam: Nā kōkua + Danger + Kūkū ❑ Phcoker

E hoʻomaopopo '

  1. Zhilyuk, VI, Levykh, AE, a me Mamchur, VI (2014). Ke Kaʻina Hana No Nā Hana Hana Hou Kūkuluʻia o nā Pyrrolidone Derivatives in Rats with Chronic Hyperglycemia. Ka Pilapala o ka biology a me nā lāʻau lapaʻau, 156(6), 799.
  2. T., Holczbauer, T., Actiņš, A., Seidel-Morgenstern, A., a me Lorenz, H. (2017). Ka noi hoʻokahi o enantiomer e crystallize i nā hui waena centrosymmetric: nā hoʻoikaika paʻa o phenylpiracetam. ʻO ka uluʻana o ka Crystal Growth & Design, 17(3), 1411-1418.
  3. Palena, RH (2016). Hoʻomākaukau i ka Hoʻoponopono Hua'ōlelo. In Ka Hoʻoulu Hua'ōlelo: Nā Kaupapa Kaupapa Ola a me nā Kuleana(pp. 1-41). ʻO Palgrave Macmillan, Lādana.
  4. Szulc, BR (2015). Ke kuhi a me kaʻikeʻana o ka hoʻouluʻana o ka hoʻolālā kōpae BRS-015: ka hopena o ka laweʻana i ka glutamatergic a me ka synaptic plasticity(Kauka Doctoral, UCL (University College London).

ʻO Shangke Chemical he polokalamu kelehana kiʻekiʻe e kū nei i nā mea hana hana hoʻopihamaha hana (APIs). No ka mālamaʻana i ka maikaʻi i ka manawa o ka hanaʻana, kahi nui o nāʻoihana akamai, nā mea hana papa hana mua a me nā hale liʻiliʻi i nā kumu nui.

Kāhea iā mā˚ou